3BZF,1KPR,1KTL,1MHE


Conserved Protein Domain Family
IgC1_MHC_Ib_HLA-E

?
cd21024: IgC1_MHC_Ib_HLA-E 
Click on image for an interactive view with Cn3D
Class Ib major histocompatibility complex (MHC) immunoglobulin domain of human leukocyte antigen (HLA) E; member of the C1-set of Ig superfamily (IgSF) domains
The members here are composed of the Class Ib major histocompatibility complex (MHC) immunoglobulin domain of human leukocyte antigen (HLA) E. HLA-E is the first human class Ib major histocompatibility complex molecule to be crystallized. Like other MHC class I molecules, HLA-E is a heterodimer consisting of an a heavy chain and light chain beta-2-microglobulin. HLA-E is highly conserved and almost nonpolymorphic, and has recently been shown to be the first specialized ligand for natural killer cell receptors. Class I MHC proteins bind antigenic peptide fragments and present them to CD8+ T lymphocytes. Class I molecules consist of a transmembrane alpha chain and a small chain called the beta-2-microglobulin. The alpha chain contains three extracellular domains, two of which fold together to form the peptide-binding cleft (alpha1 and alpha2), and one which has an Ig fold (alpha3). Peptide binding to class I molecules occurs in the endoplasmic reticulum (ER) and involves both chaperones and dedicated factors to assist in peptide loading. Class I MHC molecules are expressed on most nucleated cells.
Statistics
?
PSSM-Id: 409615
Aligned: 8 rows
Threshold Bit Score: 200.016
Created: 13-Mar-2019
Updated: 25-Oct-2021
Structure
?
Program:
Drawing:
Aligned Rows:
  next features
Conserved site includes 12 residues -Click on image for an interactive view with Cn3D
Feature 1:ligand binding site [chemical binding site]
Evidence:

Sequence Alignment
?
Format: Row Display: Color Bits: Type Selection:
Feature 1                    #         # # #                         # #####   # #               
3BZF_A       180 LHLEPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQQDGEGHTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTC 259 human
1KPR_A       180 LHLEPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQQDGEGHTQDTELVETRPAGDGTFQKWAAVVVPSGEEQAYTC 259 human
1KTL_A       180 LHLEPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQQDGEGHTQDTELVETRPAGDGTFQKWAAVVVPSGEEQAYTC 259 human
1MHE_A       180 LHLEPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQQDGEGHTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTC 259 human
NP_005507    201 LHLEPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQQDGEGHTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTC 280 human
XP_016866296 242 LHLEPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQQDGEGHTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTC 321 human
XP_016866298 201 LHLEPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQQDGEGHTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTC 280 human
P13747       201 LHLEPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQQDGEGHTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTC 280 human
Feature 1                       
3BZF_A       260 HVQHEGLPEPVTLRW 274 human
1KPR_A       260 HVQHEGLPEPVTLRW 274 human
1KTL_A       260 HVQHEGLPEPVTLRW 274 human
1MHE_A       260 HVQHEGLPEPVTLRW 274 human
NP_005507    281 HVQHEGLPEPVTLRW 295 human
XP_016866296 322 HVQHEGLPEPVTLRW 336 human
XP_016866298 281 HVQHEGLPEPVTLRW 295 human
P13747       281 HVQHEGLPEPVTLRW 295 human

| Disclaimer | Privacy statement | Accessibility |
NCBI Home NCBI Search NCBI SiteMap